These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6746710)

  • 21. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S
    Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of simultaneous administration of leupeptin on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Kakizoe T; Matsukura N; Aoyagi M; Kawachi T; Sugimura T
    Gan; 1980 Feb; 71(1):138-40. PubMed ID: 7380132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
    Ito N; Fukushima S; Shirai T; Nakanishi K
    Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats.
    Sakata T; Shirai T; Fukushima S; Hasegawa R; Ito N
    Gan; 1984 Nov; 75(11):950-6. PubMed ID: 6519396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of urinary crystals induced by acetazolamide, uracil, and diethylene glycol on urinary bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated rats.
    Masui T; Shirai T; Imaida K; Uwagawa S; Fukushima S
    Toxicol Lett; 1988 Feb; 40(2):119-26. PubMed ID: 3341053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
    Komatsu H; Kakizoe T; Nishio Y; Honma Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
    [No Abstract]   [Full Text] [Related]  

  • 31. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
    Fukushima S; Murasaki G; Hirose M; Nakanishi K; Hasegawa R; Ito N
    Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats.
    Shirai T
    Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M; Suzuki E; Hashimoto Y
    Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis.
    Shibata MA; Hagiwara A; Tamano S; Ono S; Fukushima S
    J Toxicol Environ Health; 1989; 26(3):255-65. PubMed ID: 2926828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
    Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
    Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of liarozole on the cell proliferation activity in the rat urinary bladder epithelium induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Nagae H; Otawara Y; Suzuki K; Fujita K
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):838-42. PubMed ID: 10565163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okumura M; Shirai T; Tamano S; Ito M; Yamada S; Fukushima S
    Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane potentials of urinary bladder epithelium in F344 rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium saccharin.
    Imaida K; Oshima M; Fukushima S; Ito N; Hotta K
    Carcinogenesis; 1983; 4(6):659-61. PubMed ID: 6861271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.